Disease relevance of Intra-Aortic Balloon Pumping

• A randomized prospective clinical trial compared combined treatment with intraaortic balloon pumping and intravenous nitroglycerin for 4 to 5 days with routine clinical management in 20 patients with extensive myocardium at risk for infarction as evidenced by a thallium defect score of 7.0 units or greater [1].
• Forty-two patients with cardiogenic shock (CS) secondary to myocardial infarction were treated with intra-aortic balloon pumping (I.A.B.P.). In 14 patients C.S. was associated with ventricular septal defect (V.S.D.) and in four with mitral regurgitation (M.R.) secondary to rupture of the posterior papillary muscle [2].
• In this case, the patients reach the operating theater with a risk profile that differs from the usual one due to the higher rate of cardiogenic shock (4.5 vs 0.4%), need for intra-aortic balloon pumping (14 vs 0.8%), use of antiaggregants and heparin [3].
• Respiration requiring mechanical ventilation more than 48 hours after operation occurred in four patients (10.5%) and postoperative low cardiac output requiring a high dose of dopamine HCl or intraaortic balloon pumping in nine patients (23.7%) [4].

High impact information on Intra-Aortic Balloon Pumping

• From November 1981 to November 1982, intra-aortic balloon pumping (IABP) was used after surgery in eight patients who were from 6 weeks to 6 years old and who weighed from 4.2 to 16.2 kg [5].
• In contrast, noninfarct segment length increased greater than 1.0 cm (mean increase 1.20 +/- 0.39) in five of seven patients on routine management but in none of 7 patients receiving intraaortic balloon pumping plus nitroglycerin therapy (mean decrease 0.22 +/- 0.20 cm) (p less than 0.05) [1].
• Extended use of intra-aortic balloon pumping in peripartum cardiomyopathy [6].
• High lactate predicts the failure of intraaortic balloon pumping after cardiac surgery [7].
• Adding the occurrence of reoperation, reintubation, emergency transfusion, intraaortic balloon pumping, and need for total parenteral nutrition to the model further improved its predictive capacity (AUC 94.74) [8].

Biological context of Intra-Aortic Balloon Pumping

• Thus, therapy with isosorbide dinitrate reduced left ventricular preload, and intra-aortic balloon pumping reduced blood pressure, which resulted in a decreased LVEDV and an increase in LVEF [9].
• The CPAP added to inotropic support (enoximone plus dobutamine) and intraaortic balloon pumping dramatically increased SvO2 in relation to both an increase in cardiac output and a decrease in VO2 secondary to respiratory work reduction, validating the initial hypotheses [10].

Anatomical context of Intra-Aortic Balloon Pumping

• Coronary artery bypass grafting was successfully undergone with use of propofol, application of the intra-aortic balloon pumping perioperatively, and mild hypothermic cardiopulmonary bypass with alpha-stat blood gas management [11].

Associations of Intra-Aortic Balloon Pumping with chemical compounds

• Isosorbide dinitrate and intra-aortic balloon pumping in preinfarctional angina. Effects on central circulatory dynamics [9].
• Comparison of dopamine and dobutamine therapy during intraaortic balloon pumping for the treatment of postcardiotomy low-output syndrome [12].
• Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping [13].
• Intraaortic balloon pumping was used preoperatively for anginal stabilization in 14 patients [14].
• Intraaortic balloon pumping was used in 5 control patients (11.1%) but not in the allopurinol group [15].

Gene context of Intra-Aortic Balloon Pumping

• Acute cardiac failure after repair of atrial septal defect and coronary bypass: treatment by femorofemoral assistance and intraaortic balloon pumping [16].

Analytical, diagnostic and therapeutic context of Intra-Aortic Balloon Pumping

• The efficacy of a heparin bonded ECMO system was tested in 11 patients (eight men, three women; mean age: 63 +/- 8 years), all of whom were in post cardiotomy shock refractory to inotropes and intra-aortic balloon pumping (IABP) [17].
• Constant intravenous infusion of chlorpromazine for both sedation and after-load reduction in postcardiotomy patients under intraaortic balloon pumping [18].
• The influence of glucose-insulin-potassium infusion in combination with a mechanical assist device (intraaortic balloon pumping, IABP) on the levels of high energy phosphates in the canine heart after coronary artery ligation was compared with the effect of a separate application of these measures to protect the acute ischaemic myocardium [19].

References